Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Filter Results

1313 News Releases Found

News Releases
11/17/2022

New international partnership to accelerate search for cancer cures

_
News Releases
11/15/2022

Dana-Farber Cancer Institute faculty among world’s most highly cited researchers

_
News Releases
11/15/2022

Dana-Farber Cancer Institute and the Richard K. Lubin Family Foundation announce inaugural recipients of the Lubin Family Foundation Scholar Award     

Ursula A. Matulonis, MD
News Releases
11/14/2022

Dana-Farber research supports FDA approval of new therapy for certain patients with ovarian cancer

  • Ovarian Cancer
Romanos Sklavenitis Pistofidis, MD
News Releases
11/14/2022

Study shows that immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

  • Research
  • Multiple Myeloma
Doctor holding endoscope during colonoscopy
News Releases
11/7/2022

Movie release prompts national conversation about colorectal cancer in the Black community

  • Inclusion, Diversity & Equity
  • Rectal Cancer
  • Colon Cancer
Covid-19 cell 3D illustration Getty Royalty Free RK
News Releases
11/3/2022

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated with systemic drug therapies

  • Research
Laurie H. Glimcher, MD
News Releases
10/28/2022

Dana-Farber Cancer Institute at the top of the 2022 Top 100 Women-Led Businesses in Massachusetts

Kornelia Polyak, MD, PhD
News Releases
10/17/2022

Dana-Farber’s Kornelia Polyak elected to the National Academy of Medicine

  • Breast Cancer